{"id":6651,"date":"2026-08-12T07:51:45","date_gmt":"2026-08-12T07:51:45","guid":{"rendered":"https:\/\/www.hcftir.com\/?p=6651"},"modified":"2026-08-13T07:55:39","modified_gmt":"2026-08-13T07:55:39","slug":"compliant-detection-of-pharmaceutical-raw-materials-ftir-solutions","status":"publish","type":"post","link":"https:\/\/www.hcftir.com\/ja\/compliant-detection-of-pharmaceutical-raw-materials-ftir-solutions-article\/","title":{"rendered":"How to Implement Compliant Detection of Pharmaceutical Raw Materials Using Infrared Spectroscopy"},"content":{"rendered":"

Raw materials form the absolute foundation of pharmaceutical quality control. Identifying genuine versus counterfeit raw and auxiliary materials, verifying purity, and screening for impurities represent the critical first checkpoints for compliant manufacturing. Following the implementation of the 2025 edition of the Chinese Pharmacopoeia, infrared spectrophotometry serves as a legally prescribed standard testing method. It enables pharmaceutical manufacturers to comply with GMP guidelines, mitigate quality inspection risks, and achieve fully compliant production while overcoming conventional testing bottlenecks such as cumbersome procedures, lengthy cycles, and poor data traceability.<\/p>\n\n\n\n

\"\u8d64\u5916\u5206\u5149\u6cd5\"<\/figure>\n\n\n\n

Overcoming Traditional Pharmaceutical Testing Challenges<\/h2>\n\n\n\n

Daily quality inspection in pharmaceutical manufacturing has long faced significant hurdles. Traditional chemical testing relies on complicated procedures and multi-day testing cycles that fail to satisfy rapid batch-incoming sampling demands. Furthermore, conventional methods struggle to distinguish between structurally similar raw materials and counterfeit excipients, introducing hidden production risks alongside non-standard data and insufficient traceability that invite regulatory failures.<\/p>\n\n\n\n

Fourier-transform infrared (FTIR) spectrometers utilize advanced molecular fingerprint recognition technology to precisely capture the structural characteristics of active pharmaceutical ingredients (APIs) and excipients. By comparing characteristic absorption peaks, facilities achieve rapid qualitative identification and quantitative analysis in strict alignment with pharmacopoeia testing specifications.<\/p>\n\n\n\n

\"\u8d64\u5916\u5206\u5149\u6cd5\"<\/figure>\n\n\n\n

Ensuring Pharmacopoeia Compliance and Analytical Accuracy<\/h2>\n\n\n\n

Meeting rigorous compliance and accuracy standards requires strict adherence to regulatory frameworks. By adhering to the General Principles of Infrared Spectroscopy (General Principle 0402) in the Chinese Pharmacopoeia, FTIR instruments accurately authenticate raw materials, detect purity deviations, screen for solvent residues and mixed impurities, and differentiate drug crystal structures to prevent efficacy fluctuations.<\/p>\n\n\n\n

Furthermore, integrated compliant data systems automatically store testing records with complete auditability and full traceability. This functionality satisfies GMP and pharmacopoeia data integrity requirements, protecting operations from compliance violations related to missing records or data alterations.<\/p>\n\n\n

\n
\"\u8d64\u5916\u5206\u5149\u6cd5\"<\/figure><\/div>\n\n\n

Streamlining Workflows with Versatile Testing Modes<\/h2>\n\n\n\n

Modern FTIR spectrometers satisfy full-spectrum testing demands across diverse samples, including APIs, powdered excipients, liquid solvents, and polymer packaging materials.<\/p>\n\n\n\n

Supported Testing Techniques<\/h3>\n\n\n\n